{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:04:07Z","timestamp":1789679047818,"version":"4.0.1"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"DOI":"10.1093\/hmg\/ddp548","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T03:08:22Z","timestamp":1260328102000},"page":"790-802","source":"Crossref","is-referenced-by-count":41,"title":["Duplication of Glu37 in the switch I region of HRAS impairs effector\/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation"],"prefix":"10.1093","volume":"19","author":[{"given":"Lothar","family":"Gremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Merbitz-Zahradnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dallapiccola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Morlot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Kutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"key\n\t\t\t\t20170522162335_DDP548C1","doi-asserted-by":"crossref","first-page":"15423","DOI":"10.1021\/bi0518601","article-title":"Guanine nucleotide exchange factors operate by a simple allosteric competitive mechanism","volume":"44","author":"Guo","year":"2005","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170522162335_DDP548C2","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1007\/s00018-005-5136-x","article-title":"GTPase activating proteins: structural and functional insights 18 years after discovery","volume":"62","author":"Scheffzek","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"key\n\t\t\t\t20170522162335_DDP548C3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat. Rev."},{"key":"key\n\t\t\t\t20170522162335_DDP548C4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"Wellbrock","year":"2004","journal-title":"Nat. Rev."},{"key":"key\n\t\t\t\t20170522162335_DDP548C5","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162335_DDP548C6","first-page":"4682","article-title":"RAS oncogenes in human cancer: a review","volume":"49","author":"Bos","year":"1989","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170522162335_DDP548C7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170522162335_DDP548C8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.bbamcr.2007.01.012","article-title":"Ras oncogenes and their downstream targets","volume":"1773","author":"Rajalingam","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"key\n\t\t\t\t20170522162335_DDP548C9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1126\/science.277.5324.333","article-title":"The Ras\u2013RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants","volume":"277","author":"Scheffzek","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162335_DDP548C10","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.96.12.7065","article-title":"Guanosine triphosphatase stimulation of oncogenic Ras mutants","volume":"96","author":"Ahmadian","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162335_DDP548C11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nm0306-283","article-title":"Stops along the RAS pathway in human genetic disease","volume":"12","author":"Bentires-Alj","year":"2006","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20170522162335_DDP548C12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer","volume":"7","author":"Schubbert","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"key\n\t\t\t\t20170522162335_DDP548C13","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1093\/hmg\/ddl197","article-title":"Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction","volume":"15","author":"Gelb","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.055772","article-title":"Clinical and molecular aspects of RAS related disorders","volume":"45","author":"Denayer","year":"2008","journal-title":"J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C16","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","author":"Cirstea","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/ng1641","article-title":"Germline mutations in HRAS proto-oncogene cause Costello syndrome","volume":"37","author":"Aoki","year":"2005","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140","author":"Estep","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.31047","article-title":"HRAS mutation analysis in Costello syndrome: genotype and phenotype correlation","volume":"140","author":"Gripp","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype\u2013phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/humu.20431","article-title":"Diversity, parental germline origin, and phenotypic spectrum of de novo HRAS missense changes in Costello syndrome","volume":"28","author":"Zampino","year":"2007","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522162335_DDP548C22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/jmg.2007.049270","article-title":"Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation","volume":"44","author":"van der Burgt","year":"2007","journal-title":"J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0004.2007.00931.x","article-title":"Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome","volume":"73","author":"Schulz","year":"2008","journal-title":"Clin. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.c.10019","article-title":"Costello syndrome: an overview","volume":"117","author":"Hennekam","year":"2003","journal-title":"Am. J. Med. Genet. C Semin. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0004.2007.00743.x","article-title":"HRAS and the Costello syndrome","volume":"71","author":"Rauen","year":"2007","journal-title":"Clin. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C26","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ajmg.a.32227","article-title":"Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?","volume":"146A","author":"Gripp","year":"2008","journal-title":"Am. J. Med. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/humu.20616","article-title":"Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation","volume":"29","author":"Denayer","year":"2008","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522162335_DDP548C28","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1128\/MCB.6.9.3291","article-title":"rasH mutants deficient in GTP binding","volume":"6","author":"Der","year":"1986","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C29","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.83.13.4607","article-title":"Isolation of ras GTP-binding mutants using an in situ colony-binding assay","volume":"83","author":"Feig","year":"1986","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162335_DDP548C30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.3487832","article-title":"The oncogenic activation of human p21ras by a novel mechanism","volume":"233","author":"Walter","year":"1986","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162335_DDP548C31","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1126\/science.1062023","article-title":"The guanine nucleotide-binding switch in three dimensions","volume":"294","author":"Vetter","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162335_DDP548C32","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.1128\/MCB.11.10.4822","article-title":"Dominant inhibitory mutations in the Mg(2+)-binding site of RasH prevent its activation by GTP","volume":"11","author":"Farnsworth","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C33","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/MCB.11.8.4053","article-title":"Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras","volume":"11","author":"Stacey","year":"1991","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C34","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/humu.20855","article-title":"Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome","volume":"30","author":"Rosenberger","year":"2009","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522162335_DDP548C35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ymeth.2005.05.014","article-title":"Fluorescence approaches for monitoring interactions of Rho GTPases with nucleotides, regulators, and effectors","volume":"37","author":"Hemsath","year":"2005","journal-title":"Methods"},{"key":"key\n\t\t\t\t20170522162335_DDP548C36","first-page":"45","article-title":"Fluorescence methods in the study of small GTP-binding proteins","volume":"189","author":"Ahmadian","year":"2002","journal-title":"Methods Mol. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C37","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1021\/bi962556y","article-title":"Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy","volume":"36","author":"Ahmadian","year":"1997","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170522162335_DDP548C38","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/BC.2008.132","article-title":"Fluoride complexes of oncogenic Ras mutants to study the Ras\u2013RasGap interaction","volume":"389","author":"Gremer","year":"2008","journal-title":"Biol. Chem."},{"key":"key\n\t\t\t\t20170522162335_DDP548C39","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522162335_DDP548C40","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1073\/pnas.85.14.5026","article-title":"Purification of ras GTPase activating protein from bovine brain","volume":"85","author":"Gibbs","year":"1988","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20170522162335_DDP548C41","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/351576a0","article-title":"Differential regulation of rasGAP and neurofibromatosis gene product activities","volume":"351","author":"Bollag","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162335_DDP548C42","doi-asserted-by":"crossref","first-page":"27012","DOI":"10.1016\/S0021-9258(19)74211-2","article-title":"Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, p120-GAP and neurofibromin. The significance of the intrinsic GTPase rate in determining the transforming ability of ras","volume":"268","author":"Eccleston","year":"1993","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162335_DDP548C43","first-page":"105","article-title":"Altered guanine nucleotide binding and H-ras transforming and differentiating activities","volume":"1","author":"Der","year":"1988","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170522162335_DDP548C44","doi-asserted-by":"crossref","first-page":"17700","DOI":"10.1016\/S0021-9258(19)47428-0","article-title":"p21 with a phenylalanine 28->leucine mutation reacts normally with the GTPase activating protein GAP but nevertheless has transforming properties","volume":"266","author":"Reinstein","year":"1991","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162335_DDP548C45","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1128\/MCB.13.12.7311","article-title":"Effector domain mutations dissociate p21ras effector function and GTPase-activating protein interaction","volume":"13","author":"Stone","year":"1993","journal-title":"Mol. Cell. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C46","doi-asserted-by":"crossref","first-page":"9157","DOI":"10.1016\/S0021-9258(18)98325-0","article-title":"Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target","volume":"268","author":"Polakis","year":"1993","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20170522162335_DDP548C47","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/emboj.2008.125","article-title":"Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II","volume":"27","author":"Stieglitz","year":"2008","journal-title":"EMBO J."},{"key":"key\n\t\t\t\t20170522162335_DDP548C48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/28548","article-title":"The structural basis of the activation of Ras by Sos","volume":"394","author":"Boriack-Sjodin","year":"1998","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162335_DDP548C49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(90)90018-A","article-title":"Three-dimensional structures of H-ras p21 mutants: molecular basis for their inability to function as signal switch molecules","volume":"62","author":"Krengel","year":"1990","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162335_DDP548C50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0092-8674(95)90507-3","article-title":"Multiple Ras functions can contribute to mammalian cell transformation","volume":"80","author":"White","year":"1995","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162335_DDP548C51","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1126\/science.271.5250.810","article-title":"Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS","volume":"271","author":"Joneson","year":"1996","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522162335_DDP548C52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(00)80226-3","article-title":"Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras","volume":"89","author":"Rodriguez-Viciana","year":"1997","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170522162335_DDP548C53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/370527a0","article-title":"Phosphatidylinositol-3-OH kinase as a direct target of Ras","volume":"370","author":"Rodriguez-Viciana","year":"1994","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522162335_DDP548C54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0959-440X(02)00007-6","article-title":"Ras\u2013effector interactions: after one decade","volume":"13","author":"Herrmann","year":"2003","journal-title":"Curr. Opin. Struct. Biol."},{"key":"key\n\t\t\t\t20170522162335_DDP548C55","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/prot.21321","article-title":"COMBINE analysis of the specificity of binding of Ras proteins to their effectors","volume":"67","author":"Tomic","year":"2007","journal-title":"Proteins"},{"key":"key\n\t\t\t\t20170522162335_DDP548C56","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170522162335_DDP548C57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522162335_DDP548C58","volume-title":"The Griffiths Mental Development Scales 1996 Revision","author":"Griffiths","year":"1996"},{"key":"key\n\t\t\t\t20170522162335_DDP548C59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0378-1119(91)90539-N","article-title":"A general method for introducing a series of mutations into cloned DNA using the polymerase chain reaction","volume":"102","author":"Ito","year":"1991","journal-title":"Gene"},{"key":"key\n\t\t\t\t20170522162335_DDP548C60","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/508474","article-title":"Mutations of the mitochondrial holocytochrome c-type synthase in X-linked dominant microphthalmia with linear skin defects syndrome","volume":"79","author":"Wimplinger","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522162335_DDP548C61","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.onc.1201005","article-title":"Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras","volume":"14","author":"de Rooij","year":"1997","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170522162335_DDP548C62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1042\/BJ20081535","article-title":"A BAR domain-mediated autoinhibitory mechanism for RhoGAPs of the GRAF family","volume":"417","author":"Eberth","year":"2009","journal-title":"Biochem. J."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/19\/5\/790\/17250719\/ddp548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T19:15:54Z","timestamp":1634325354000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddp548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,8]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,12,8]]},"published-print":{"date-parts":[[2010,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddp548","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12,8]]}}}